Medicare Enrolled
Dr. Justin Winas, D.O.
Pain Medicine · Fort Washington, PA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Winas from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Winas?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Winas
Dr. Justin Winas is a pain medicine specialist in Fort Washington, PA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Winas performed 9,878 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Winas received a total of $9,316 from 45 pharmaceutical and/or device companies across 403 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Winas is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 2% volume in PA
$9,316 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗9,878
Medicare services
Top 2% in PA for pain medicine
Not available
Unique patients (not deduplicated)
$33
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
2,381 | $0 | $1 |
| Assessment of emotional or behavioral problems An evaluation to identify and understand emotional or behavioral issues. This process involves reviewing symptoms and behaviors to determine the nature of the concerns. |
2,244 | $4 | $65 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,196 | $98 | $270 |
| Health risk assessment administration and interpretation This procedure involves administering a health risk assessment to a patient and interpreting the results. |
852 | $2 | $12 |
| Contrast dye for imaging, lower concentration | 817 | $0 | $2 |
| Psychological test administration, first 30 minutes A technician administers psychological or neuropsychological testing for the first 30 minutes. |
669 | $27 | $120 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
442 | $11 | $110 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
199 | $73 | $185 |
| Drug screening test A laboratory test that uses a chemistry analyzer to detect the presence of drugs in a sample. |
147 | $61 | $210 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
144 | $242 | $740 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
142 | $195 | $595 |
| Injection into lower spine canal with imaging guidance A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement. |
102 | $209 | $2,300 |
| Trigger point injection, 3 or more muscles Injection of medication into three or more specific muscle trigger points to relieve pain. |
82 | $51 | $330 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
68 | $130 | $430 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement. |
53 | $192 | $3,442 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
45 | $53 | $363 |
| Fluoroscopic guidance for needle placement Use of real-time X-ray imaging to guide the precise placement of a needle during a medical procedure. |
43 | $96 | $360 |
| Remote therapeutic monitoring, first 20 minutes Physician management of remote therapeutic monitoring data for the first 20 minutes per calendar month. |
33 | $40 | $150 |
| Injection of anesthetic or steroid into sacroiliac joint with imaging guidance This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection. |
30 | $138 | $1,525 |
| Facet joint nerve destruction, single joint A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals. |
30 | $366 | $3,493 |
| Sacral spine nerve root injection with imaging guidance An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement. |
28 | $234 | $3,541 |
| Facet joint injection, second level, with imaging guidance An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated. |
25 | $88 | $1,459 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
23 | $153 | $520 |
| Additional sacral spine nerve root injection with imaging An injection of anesthetic and/or steroid medication into an additional sacral spine nerve root level, guided by imaging. |
18 | $97 | $1,578 |
| Spinal injection with imaging guidance A procedure where medication is injected into the middle or upper part of the spinal canal. Imaging technology is used to guide the needle to the correct location. |
17 | $211 | $2,330 |
| Remote therapy monitoring setup and education This service involves setting up equipment and providing patient education for the remote monitoring of therapy. |
17 | $16 | $60 |
| Balance and posture test A test to evaluate a patient's balance and posture. This assessment measures stability and body alignment. |
16 | $36 | $300 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint. |
15 | $202 | $1,530 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$9,316
Total received (2018-2024)
Avg $1,331/year across 7 years
Top 15% in PA for pain medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
45
Companies
403
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,306
2023
$882
2022
$819
2021
$646
2020
$872
2019
$1,355
2018
$2,436
Payments by company (2024)
Boston Scientific Corporation
$928
Vertos Medical, Inc.
$340
BIOTRONIK NRO, Inc.
$248
Collegium Pharmaceutical, Inc.
$232
Abbott Laboratories
$152
ABBVIE INC.
$60
Averitas Pharma Inc.
$44
Medtronic, Inc.
$42
Nevro Corp.
$40
AstraZeneca Pharmaceuticals LP
$36
Nalu Medical, Inc.
$34
Saluda Medical Americas, Inc.
$33
IBSA Pharma Inc.
$23
Electronic Waveform Lab, Inc.
$22
VERTEX PHARMACEUTICALS INCORPORATED
$19
PFIZER INC.
$18
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$18
ConvaTec Inc.
$16
Top 3 companies account for 65.8% of 2024 payments
All-time payments by company (2018-2024) ›
Boston Scientific Corporation
$1,255
Medtronic USA, Inc.
$1,144
Abbott Laboratories
$1,020
Collegium Pharmaceutical, Inc.
$920
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$803
Nevro Corp.
$784
Vertos Medical, Inc.
$640
Daiichi Sankyo Inc.
$437
BIOTRONIK NRO, Inc.
$334
SCILEX PHARMACEUTICALS INC.
$248
Medtronic, Inc.
$177
BioDelivery Sciences International, Inc.
$149
Kaleo, Inc.
$129
Relievant Medsystems, Inc.
$117
PFIZER INC.
$105
AbbVie Inc.
$101
ARBOR PHARMACEUTICALS, INC.
$95
Vertiflex, Inc.
$71
Scilex Pharmaceuticals Inc.
$67
ABBVIE INC.
$60
Biohaven Pharmaceutical Holding Company Ltd.
$49
IBSA Pharma Inc.
$48
Averitas Pharma Inc.
$44
Shionogi Inc
$39
Forte Bio-Pharma LLC
$36
AstraZeneca Pharmaceuticals LP
$36
FORTE BIO-PHARMA LLC
$36
Electronic Waveform Lab, Inc.
$34
Nalu Medical, Inc.
$34
Saluda Medical Americas, Inc.
$33
Egalet US Inc
$28
Sentynl Therapeutics, Inc.
$27
RedHill Biopharma Inc.
$20
VERTEX PHARMACEUTICALS INCORPORATED
$19
Lilly USA, LLC
$19
BOSTON SCIENTIFIC CORPORATION
$18
MML US, Inc.
$18
Foundation Fusion Solutions, LLC
$18
Takeda Pharmaceuticals U.S.A., Inc.
$18
GRT US Holding, Inc.
$16
ConvaTec Inc.
$16
Indivior Inc.
$15
Purdue Pharma L.P.
$15
Teva Pharmaceuticals USA, Inc.
$11
Horizon Pharma plc
$11
Top 3 companies account for 36.7% of all-time payments
Associated products mentioned in payments ›
ADAPTIVESTIM · AJOVY · AMPERE · AQUACEL AG+ EXTRA · ARYMO ER · Amitiza · Axium INS DRG IPG · Axium Sheath Braided DRG · BELBUCA · BIOTRONIK · BUNAVAIL 2.1 mg 30-count box · Belbuca · CHANTIX · EMGALITY · ETERNA · EVZIO · Edarbi · Evoke · Evzio · GENERAL PAIN MANAGEMENT · GENERAL - PAIN MANAGEMENT · GENERAL PAIN MANAGEMENT · General - Pain Management · Horizant · INTELLIS · INTELLIS ADAPTIVESTIM · Intracept · LICART · LYRICA · Levorphanol · Morphabond ER · Movantik · NURTEC ODT · Nalocet · Nalu Neurostimulation System · Neuromodulation Dspsbls and Accs · OCTRODE · Octrode SCS Leads · Omnia · PAXLOVID · PENNSAID · PENTA · PROCLAIM · PROLATE · Penta SCS Leads · Proclaim Family of SCS IPGs · Proclaim IPG · Prospera · QULIPTA · QUTENZA · Qutenza · RELISTOR · RELISTOR ORAL · RESTORE · ReActiv8 · SCS IPGs · SPECTRA WAVEWRITER · SPRIX · SUBLOCADE · SYMPROIC · SYNCHROMEDII · Senza · Senza Spinal Cord Stimulation System · Spinal Cord Stimulation Accessories · Superion ISS · Swift-Lock SCS · Symproic · Tirosint · UBRELVY · WAINUA · WaveWriter Alpha Prime 16 · XTAMPZA · XTAMPZAER · Xtampza ER · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · mild Device Kit
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Pain medicines in nearby ZIP areas
86
County median income
$111,521
Nearest hospital to ZIP centroid (approximate)
BROOKE GLEN BEHAVIORAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Winas is a mixed practice specialist, with above-average Medicare volume (top 2% in PA), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Winas experienced with dexamethasone injection (steroid)?
Based on Medicare claims data, Dr. Winas performed 2,381 dexamethasone injection (steroid) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Winas receive payments from pharmaceutical companies?
Yes. Dr. Winas received a total of $9,316 from 45 companies across 403 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Winas's costs compare to other pain medicines in Fort Washington?
Dr. Winas's average Medicare payment per service is $33. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Winas) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Pain Medicines in Fort Washington
Browse pain medicines in Fort Washington ranked by procedure volume and transparency data.
Highest volume
Top Pain Medicines in PA
Pain medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pain Medicines in PA
Which PA pain medicines receive the most from drug and device companies.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
Medtronic USA, Inc. Payments to Doctors
See all physicians who received payments from Medtronic USA, Inc.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology